173 related articles for article (PubMed ID: 25897176)
1. Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.
Scialis RJ; Csanaky IL; Goedken MJ; Manautou JE
Drug Metab Dispos; 2015 Jul; 43(7):944-50. PubMed ID: 25897176
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites.
Scialis RJ; Aleksunes LM; Csanaky IL; Klaassen CD; Manautou JE
Drug Metab Dispos; 2019 Oct; 47(10):1080-1092. PubMed ID: 31399506
[TBL] [Abstract][Full Text] [Related]
3. Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine.
Zhu Y; Zhang QY
J Pharmacol Exp Ther; 2012 Nov; 343(2):362-70. PubMed ID: 22892338
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity.
Scialis RJ; Manautou JE
J Pharmacol Exp Ther; 2016 Apr; 357(1):167-76. PubMed ID: 26869668
[TBL] [Abstract][Full Text] [Related]
5. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
Lagas JS; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Mol Pharmacol; 2010 Apr; 77(4):687-94. PubMed ID: 20086033
[TBL] [Abstract][Full Text] [Related]
6. Consequences of Mrp2 deficiency for diclofenac toxicity in the rat intestine ex vivo.
Niu X; de Graaf IA; van de Vegte D; Langelaar-Makkinje M; Sekine S; Groothuis GM
Toxicol In Vitro; 2015 Feb; 29(1):168-75. PubMed ID: 25450747
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice.
LoGuidice A; Wallace BD; Bendel L; Redinbo MR; Boelsterli UA
J Pharmacol Exp Ther; 2012 May; 341(2):447-54. PubMed ID: 22328575
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites.
Niu X; de Graaf IA; Langelaar-Makkinje M; Horvatovich P; Groothuis GM
Arch Toxicol; 2015 Jan; 89(1):107-19. PubMed ID: 24770551
[TBL] [Abstract][Full Text] [Related]
10. Toxicological role of an acyl glucuronide metabolite in diclofenac-induced acute liver injury in mice.
Oda S; Shirai Y; Akai S; Nakajima A; Tsuneyama K; Yokoi T
J Appl Toxicol; 2017 May; 37(5):545-553. PubMed ID: 27671914
[TBL] [Abstract][Full Text] [Related]
11. Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy.
Ramirez-Alcantara V; LoGuidice A; Boelsterli UA
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G990-8. PubMed ID: 20501447
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions.
Ware JA; Graf ML; Martin BM; Lustberg LR; Pohl LR
Chem Res Toxicol; 1998 Mar; 11(3):164-71. PubMed ID: 9544613
[TBL] [Abstract][Full Text] [Related]
13. Increase in covalent binding of 5-hydroxydiclofenac to hepatic tissues in rats co-treated with lipopolysaccharide and diclofenac: involvement in the onset of diclofenac-induced idiosyncratic hepatotoxicity.
Kishida T; Onozato T; Kanazawa T; Tanaka S; Kuroda J
J Toxicol Sci; 2012; 37(6):1143-56. PubMed ID: 23208430
[TBL] [Abstract][Full Text] [Related]
14. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.
Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B
J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153
[TBL] [Abstract][Full Text] [Related]
15. Roles of diclofenac and its metabolites in immune activation associated with acute hepatotoxicity in TgCYP3A4/hPXR-humanized mice.
Jiang W; Dai T; Xie S; Ding L; Huang L; Dai R
Int Immunopharmacol; 2020 Sep; 86():106723. PubMed ID: 32615451
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Reactive Metabolites of Diclofenac in Cytotoxicity in Sandwich-Cultured Rat Hepatocytes.
Kawase A; Hashimoto R; Shibata M; Shimada H; Iwaki M
Int J Toxicol; 2017; 36(3):260-267. PubMed ID: 28553770
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of multidrug resistance-associated protein 3 (mrp3/abcc3) in the basolateral efflux of glucuronide conjugates in the mouse small intestine.
Kitamura Y; Kusuhara H; Sugiyama Y
J Pharmacol Exp Ther; 2010 Feb; 332(2):659-66. PubMed ID: 19889793
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the immunogenicity of diclofenac and diclofenac metabolites.
Naisbitt DJ; Sanderson LS; Meng X; Stachulski AV; Clarke SE; Park BK
Toxicol Lett; 2007 Jan; 168(1):45-50. PubMed ID: 17123753
[TBL] [Abstract][Full Text] [Related]
19. Distribution of intraperitoneally injected diclofenac in brown trout (Salmo trutta f. fario).
Hoeger B; Dietrich DR; Schmid D; Hartmann A; Hitzfeld B
Ecotoxicol Environ Saf; 2008 Oct; 71(2):412-8. PubMed ID: 18068779
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.
Goswami SK; Rand AA; Wan D; Yang J; Inceoglu B; Thomas M; Morisseau C; Yang GY; Hammock BD
Life Sci; 2017 Jul; 180():114-122. PubMed ID: 28522175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
